JURK; Marion

Patent Applications and Registrations

Patent applications and USPTO patent grants for JURK; Marion.The latest application filed is for "method for introducing nucleic acids into a cell".

Company Profile

1.15.20

JURK; Marion - Pulheim DE
Jurk; Marion - Dormagen DE
Jurk; Marion - Dusseldorf DE
Jurk, Marion - Duesseldorf DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Introducing Nucleic Acids Into A Cell App 20190144886 - JURK; Marion ; et al.	2019-05-16
CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity Grant 10,260,071 - Debelak , et al.	2019-04-16
Inhibitory Oligonucleotides And Their Use In Therapy App 20160355822 - Uhlmann; Eugen ; et al.	2016-12-08
CpG Oligonucleotide Analogs Containing Hydrophobic T Analogs with Enhanced Immunostimulatory Activity App 20160348115 - Debelak; Harald ; et al.	2016-12-01
CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity Grant 9,382,545 - Debelak , et al. July 5, 2	2016-07-05
Inhibitory Oligonucleotides And Their Use In Therapy App 20150344884 - UHLMANN; Eugen ; et al.	2015-12-03
Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity Grant 9,200,287 - Uhlmann , et al. December 1, 2	2015-12-01
Immune stimulatory oligonucleotide analogs containing modified sugar moieties Grant 9,186,399 - Uhlmann , et al. November 17, 2	2015-11-17
CpG Oligonucleotide Analogs Containing Hydrophobic T Analogs with Enhanced Immunostimulatory Activity App 20140163213 - Debelak; Harald ; et al.	2014-06-12
CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity Grant 8,580,268 - Debelak , et al. November 12, 2	2013-11-12
RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles Grant 8,466,124 - Jurk , et al. June 18, 2	2013-06-18
Immunostimulatory nucleic acids Grant 8,304,396 - Krieg , et al. November 6, 2	2012-11-06
Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages Inducing Specific Immune Modulatory Profiles App 20120258140 - Jurk; Marion ; et al.	2012-10-11
Immunostimulatory nucleic acids Grant 8,283,328 - Krieg , et al. October 9, 2	2012-10-09
RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles Grant 8,227,447 - Jurk , et al. July 24, 2	2012-07-24
Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages Inducing Specific Immune Modulatory Profiles App 20120121648 - Jurk; Marion ; et al.	2012-05-17
RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles Grant 8,128,944 - Jurk , et al. March 6, 2	2012-03-06
5' CpG nucleic acids and methods of use Grant 7,956,043 - Krieg , et al. June 7, 2	2011-06-07
Immune Stimulatory Oligonucleotide Analogs Containing Modified Sugar Moieties App 20110098456 - Uhlmann; Eugen ; et al.	2011-04-28
Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages Inducing Specific Immune Modulatory Profiles App 20100272785 - Jurk; Marion ; et al.	2010-10-28
Phosphate-Modified Oligonucleotide Analogs with Enhanced Immunostimulatory Activity App 20100261779 - Uhlmann; Eugen ; et al.	2010-10-14
Compositions of TLR ligands and antivirals App 20100189772 - Vollmer; Jorg ; et al.	2010-07-29
CpG Oligonucleotide Analogs Containing Hydrophobic T Analogs with Enhanced Immunostimulatory Activity App 20100166780 - Debelak; Harald ; et al.	2010-07-01
Oligoribonucleotides and uses thereof App 20100144846 - Jurk; Marion ; et al.	2010-06-10
Modulation of Immunostimulatory Properties of Short Interfering Ribonucleic Acid (Sirna) by Nucleotide Modification App 20090306177 - Uhlmann; Eugen ; et al.	2009-12-10
Immunostimulatory nucleic acids App 20070224210 - Krieg; Arthur M. ; et al.	2007-09-27
Methods and products for enhancing immune responses using imidazoquinoline compounds App 20060188913 - Krieg; Arthur M. ; et al.	2006-08-24
Sequence requirements for inhibitory oligonucleotides App 20050239733 - Jurk, Marion ; et al.	2005-10-27
Immunostimulatory nucleic acids App 20050059619 - Krieg, Arthur M. ; et al.	2005-03-17
5' CpG nucleic acids and methods of use App 20040171571 - Krieg, Arthur M. ; et al.	2004-09-02
Methods and products for enhancing immune responses using imidazoquinoline compounds App 20030139364 - Krieg, Arthur M. ; et al.	2003-07-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.